Here's a post from Josh Hill at ThinkGene about an unpublished study of Blue Light effect on tumors in mice. It's a hands-down winner of today's Snake Oil of the Day Award. Lest we give cancer patients and the general public false hope and the wrong impression, it might be wise to let one like this at least get through peer review before sensationalizing it...
« Survival in Prostate Cancer: It May Be Affected By Your Genes | Main | Where You Get Your Mammogram Matters! »
June 24, 2008
TrackBack
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00e54ede860c883300e5536f6d288833
Listed below are links to weblogs that reference Snake Oil Alert: Blue Light Cancer Treatment at ThinkGene:
Comments
You can follow this conversation by subscribing to the comment feed for this post.
Verify your Comment
Previewing your Comment
This is only a preview. Your comment has not yet been posted.
Your comment could not be posted. Error type:
Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment
As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.
Having trouble reading this image? View an alternate.
Search
Categories
- BRCA1
- BRCA2
- Breast Cancer
- Breast MRI
- Breast Reconstruction
- BRIP1
- Cancer
- Cancer Genetics
- Cancer Prevention
- Cancer Screening
- Cancer Survival
- Childhood Cancer
- Cisplatin
- Colon Cancer
- Colon Cancer Screening
- Common Disease, Common Gene Hypothesis
- Common Disease, Rare Gene/Rare Allele Hypothesis
- ELSI (Ethical, Legal, and Social Issues)
- Familial Adenomatous Polyposis (FAP)
- Family History
- Famous People
- Fanconi Anemia
- Gastric Cancer
- Genome-wide Association Studies
- GINA
- Hereditary Breast and Ovarian Cancer
- Imaging
- Lung Cancer
- Lymphoma
- Lynch Syndrome/HNPCC
- Mammograms
- Melanoma
- Molecularly Targeted Therapy
- Non-Hodgkin Lymphoma
- Ovarian Cancer
- PALB2
- Pancreatic Cancer
- PARP Inhibitors
- Prophylactic Mastectomy
- Prostate Cancer
- RAD51C
- RAD51D
- Risk-Reducing Salpingo-Oophorectomy
- Skin Cancer
- Snake Oil
- Weblogs
- Wilms Tumor
Recent Posts
- Mutations in the DIS3L2 Gene Cause Perlman Syndrome: Another Key Clue in Unraveling the Puzzle of Wilms Tumor Development
- Other Cancers Seen in Families with RAD51D Mutations
- RAD51D - A New Hereditary Ovarian Cancer Gene With Important Implications
- New BRCA1 Single Molecule Sequencing Method Published
- Family History of Cancer Changes Over Time: Why You Need to Keep Your Primary Care Doctor Updated
- New Financial Assistance Program for Young Women with BRCA1 and BRCA2 Mutations Needing Help Paying for Screening Breast MRI
- More on the Woman Who Filed an EEOC Complaint Claiming She Was Fired Over a Genetic Test Revealing a BRCA2 Mutation
- Myriad Genetics Has Raised The Price for BRCA1 and BRCA2 Testing: North of $4,000 Now
- Woman Files Complaint Claiming She Was Fired Over Positive BRCA2 Test for Hereditary Breast and Ovarian Cancer
- Myriad Breast Cancer Gene Patents and the Courts: Upcoming Genetic Alliance Webinar
DNA and You
Around The Web
- American Society of Human Genetics
- BRCAscoop
- BRCAscoop Blog
- CAGC
- Cancer and Your Genes
- CGS - Biopolitical Times
- DNA and You
- e-Patients.net
- Evinome
- Genetic Alliance
- Genetic Future
- Genomics Law Report
- HUGO Matters
- Kevin, M.D.
- NSGC Public Policy Update
- NYT: Well
- PredictER Blog
- ScienceRoll
- The Body Odd
- The Decision Tree
- The DNA Exchange
- WSJ: Health Blog
Hi Matt,
I'm Andrew Yates, the editor of Think Gene. You're right, Josh made a small mistake, and so did I for not catching this one. I've removed the article (which now links to a retraction message). Thanks for keep us on our toes!
-Andrew Yates
www.thinkgene.com
Posted by: Andrew Yates | June 25, 2008 at 05:46 PM